AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 267 filers reported holding AVANOS MED INC in Q3 2021. The put-call ratio across all filers is 3.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $513,756 | -22.5% | 20,100 | -9.9% | 0.00% | 0.0% |
| Q1 2023 | $663,202 | -92.2% | 22,300 | -91.2% | 0.00% | -93.8% |
| Q1 2022 | $8,493,000 | +650.9% | 253,525 | +677.7% | 0.02% | +700.0% |
| Q4 2021 | $1,131,000 | +15.3% | 32,601 | +3.7% | 0.00% | -50.0% |
| Q3 2021 | $981,000 | -54.0% | 31,441 | -35.6% | 0.00% | -60.0% |
| Q1 2021 | $2,134,000 | +12.7% | 48,785 | -14.4% | 0.01% | -16.7% |
| Q3 2020 | $1,894,000 | -52.8% | 57,024 | -58.2% | 0.01% | -57.1% |
| Q2 2020 | $4,010,000 | +109.2% | 136,472 | +91.7% | 0.03% | +47.4% |
| Q1 2020 | $1,917,000 | +53.7% | 71,194 | +113.9% | 0.02% | +90.0% |
| Q3 2019 | $1,247,000 | -83.3% | 33,280 | -80.5% | 0.01% | -83.6% |
| Q2 2019 | $7,460,000 | +98.1% | 171,064 | +94.0% | 0.06% | +238.9% |
| Q1 2019 | $3,766,000 | -46.0% | 88,190 | -43.4% | 0.02% | -74.6% |
| Q4 2018 | $6,979,000 | -31.2% | 155,837 | +5.2% | 0.07% | +65.1% |
| Q3 2018 | $10,144,000 | – | 148,102 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,310,272 | $63,163,000 | 4.83% |
| RGM Capital, LLC | 2,978,889 | $81,443,000 | 4.25% |
| Tributary Capital Management, LLC | 586,117 | $16,024,000 | 1.59% |
| HEARTLAND ADVISORS INC | 395,141 | $10,803,000 | 0.75% |
| Hillsdale Investment Management Inc. | 169,400 | $4,631,000 | 0.37% |
| WESTWOOD HOLDINGS GROUP INC | 1,068,905 | $29,225,000 | 0.32% |
| Keene & Associates, Inc. | 11,642 | $318,000 | 0.30% |
| Wakefield Asset Management LLLP | 24,356 | $666,000 | 0.28% |
| CORNERCAP INVESTMENT COUNSEL INC | 36,025 | $985,000 | 0.17% |
| GSA CAPITAL PARTNERS LLP | 26,366 | $721,000 | 0.11% |